Literature DB >> 24890450

Breast cancer: from Halsted to Harney.

Malcolm R Kell1.   

Abstract

The management of breast cancer has evolved in the last 40 years to now encompass not only treating the cancer in the most effective way, but also to detect and treat cancers before they can pose a risk to patients. This evolution in therapy and diagnostics has moved away from treating patients with the maximum amount of therapy they can tolerate towards a new paradigm where patents receive the minimum treatment to be most efficacious.

Entities:  

Mesh：

Year:  2014        PMID： 24890450     DOI： 10.1007/s11845-014-1142-z

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


  18 in total

1.  Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage IV breast cancer impacts on survival.

Authors:  Elly Harris; Mitchel Barry; Malcolm R Kell
Journal:  Ann Surg Oncol       Date:  2013-05-08       Impact factor: 5.344

Review 2.  Breast cancer screening: the evolving evidence.

Authors:  Robert A Smith; Stephen W Duffy; László Tabár
Journal:  Oncology (Williston Park)       Date:  2012-05       Impact factor: 2.990

3.  Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation.

Authors:  H Meijers-Heijboer; B van Geel; W L van Putten; S C Henzen-Logmans; C Seynaeve; M B Menke-Pluymers; C C Bartels; L C Verhoog; A M van den Ouweland; M F Niermeijer; C T Brekelmans; J G Klijn
Journal:  N Engl J Med       Date:  2001-07-19       Impact factor: 91.245

4.  Immediate reconstruction after mastectomy for breast cancer does not prolong the time to starting adjuvant chemotherapy.

Authors:  Tanir M Allweis; Marc E Boisvert; Susan E Otero; David J Perry; Norman H Dubin; Dennis A Priebat
Journal:  Am J Surg       Date:  2002-03       Impact factor: 2.565

5.  Effect of occult metastases on survival in node-negative breast cancer.

Authors:  Donald L Weaver; Takamaru Ashikaga; David N Krag; Joan M Skelly; Stewart J Anderson; Seth P Harlow; Thomas B Julian; Eleftherios P Mamounas; Norman Wolmark
Journal:  N Engl J Med       Date:  2011-01-19       Impact factor: 91.245

6.  A comparative study of risk factors and prognostic features between symptomatic and screen detected breast cancer.

Authors:  J P Burke; C Power; T F Gorey; F Flanagan; M J Kerin; M R Kell
Journal:  Eur J Surg Oncol       Date:  2007-05-10       Impact factor: 4.424

Review 7.  Screening for breast cancer: an update for the U.S. Preventive Services Task Force.

Authors:  Heidi D Nelson; Kari Tyne; Arpana Naik; Christina Bougatsos; Benjamin K Chan; Linda Humphrey
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

8.  American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

Authors: 
Journal:  J Clin Oncol       Date:  2003-04-11       Impact factor: 44.544

9.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Authors:  Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

10.  Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ.

Authors:  Clive Dunne; John P Burke; Monica Morrow; Malcolm R Kell
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.